CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


22-January-2013
Introducing a certified solution standard of the new anticonvulsant drug Retigabine. 


Retigabine, 1.0 mg/mL R-018
1.0 mg/mL in Acetonitrile

Retigabine, also known as ezogabine, is a new antiepileptic drug developed for treatment of partial seizures. The drug is marketed under the trade names Potiga® in the US and Trobalt® in the EU. This certified solution standard is suitable for use as starting material in calibrators and controls for LC/MS or GC/MS methods in clinical toxicology, forensic analysis, urine drug testing, pain prescription monitoring, or pharmaceutical research applications.

Cerilliant will soon introduce certified solution standards of the internal standard Retigabine-D4 and N-Acetylretigabine, a major urinary metabolite of retigabine.



Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn